Conference abstract · 21 Jun 2017
Conference abstractPublished 20 Jun 2016
Hidden activities of known antibiotics revealed by molecular docking of batumin, mupirocin and bacillaen
University of Pretoria, South Africa; Institute of Microbiology and Virology, Ukraine; R.E.Kavetsky Institute of Experimental Pathology, Ukraine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Antibiotics of the family mupirocin/batumin/bacillaen encoded by larger NRPS-PKS operons are secondary metabolites of many phylogenetically unrelated bacteria from Preudomonas to Bacillus. Mupirocin and batumin were found to be active against drug MRSA Staphylococcus aureus, but the biological role of these compounds synthesized but several strains of Pseudomonas from rhizosphere remained unclear. In this study we used molecular docking approaches and querying of predicted chemical structures through the PharmaDB database of designed pharmacophores to identify possible molecular targets for these antibiotics. The mechanism of inhibition of S. aureus by targeting tRNA synthetases by these antibiotics was confirmed. Additionally, it was found that mupirocin, batumin and bacillaen might target bacterial MotB flagellar motor switch protein. Inhibition of the flagellar movement of phytopathogenic bacteria by mupirocin and batumin was proved experimentally. Other predicted possible targets for these antibiotics were several tumor suppressors. Screening of the activity of batumin on the LLC (Lewis lung carcinoma) cell lines showed a promising activity by the mechanism of cell cycle arrest at G1/S checkpoint via activation of retinoblastoma protein and down-regulation of the cyclin D1. This study showed that the known antibiotics may have much wider range of activities. Modern methods of computational analysis and modeling of molecular interactions will help in finding non-traditional areas of application of the old antibiotics instead of designing new ones.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 2013
Molecular Revealing of Non-Tuberculous Mycobacterium-Clinical Usage to Diagnose Hidden Danger
Research article · 3 Oct 2022
Molecular Docking Structure-Activity Relationship, ADMET Evaluation and Pharmacokinetics Studies of Anti-HIV Agents and Methyl-Diarylpyrimidines Non-Nucleoside Reverse Transcriptase Inhibitors
Research article · 30 May 2022
In-Vivo Antinociceptive Activity and In-Silico Molecular Docking of Selected Phytoconstituents of Methanolic Extract of Hypericum Japonicum
Research article · 31 Mar 2022
Network Pharmacology Based and Molecular Docking Prediction of the Active Ingredients and Mechanism of Ziziphi spinosae semen-Schisandrae chinensis fructus for Application in Insomnia Treatment
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Oleg Reva”
- BylineArticles whose byline prints “Klochko V V”
- BylineArticles whose byline prints “Zhuravel E V”
- BylineArticles whose byline prints “Soldatkina M A”

